Skip to content

Tyra Biosciences, Inc. TYRA Total Current Assets

Total Current Assets at other companies

Incyte logo
IncyteINCY
$5.48B+56.4%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$4.61B+32.8%
UroGen Pharma logo
UroGen PharmaURGN
$237.46M+0.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.24B+78.6%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$348.7M+87.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$471.18M-14.1%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.79B+318%
Enterprise value$1.71B+397%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s total current assets?
Tyra Biosciences, Inc. (TYRA) reported total current assets of $394.61M in Q1 2026.
How has Tyra Biosciences, Inc.'s total current assets changed year-over-year?
Tyra Biosciences, Inc.'s total current assets increased by 21.6% year-over-year, from $324.57M to $394.61M.
What is the long-term trend for Tyra Biosciences, Inc.'s total current assets?
Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total current assets has grown at a 77.0% compound annual growth rate (CAGR), from $15.28M to $265.45M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.